1,625
Views
1
CrossRef citations to date
0
Altmetric
Articles

Do negative intrusive thoughts at diagnosis predict impaired quality of life, depressed mood and waking up with anxiety 3, 12 and 24 months after radical prostatectomy? – a longitudinal study

, , , ORCID Icon, , , , ORCID Icon, , , ORCID Icon, , & show all
Pages 220-226 | Received 27 Dec 2019, Accepted 08 Apr 2020, Published online: 28 Apr 2020
 

Abstract

Objective: To evaluate the effect of intrusive thoughts at diagnosis on quality of life, depressed mood and waking up with anxiety up to two years after radical prostatectomy.

Method: The Laparoscopic Prostatectomy Robot Open (LAPPRO) trial was a prospective, longitudinal multicenter study of 4003 patients undergoing radical prostatectomy. Questionnaire data were collected preoperatively, at 3, 12 and 24 months after surgery.

Results: The group of patients with intrusive thoughts at diagnosis had a statistically significant higher postoperative prevalence of impaired quality of life, depressed mood and waking up with anxiety as compared with the group of patients with no or minor intrusive thoughts. The highest risk increase for impaired QoL, depressed mood and waking up with anxiety ≥1/week was at 12, 3 and 3 months, respectively, where the three outcomes increased by 38% (RR: 1.38; 95%CI: 1.27–1.49)), 136% (RR: 2.36; 95%CI: 1.74–3.19)) and 165% (RR: 2.65; 95%CI: 2.22–3.17)), respectively.

Conclusions: The demonstrated link between intrusive thoughts and quality of life, depressed mood and waking up with anxiety deliver is further evidence to the idea that intrusive thoughts has potential as an endpoint for assessing and predicting psychological distress among men with prostate cancer diagnosis.

Trial registration number: ISRCTN06393679 (www.isrctn.com). Date of registration: 07/02/2008. Retrospectively registered.

Acknowledgements

The authors gratefully acknowledge the participants in the LAPPRO trial.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This study was supported by research grants from the Swedish Cancer Society [2008/922, 2010/593, 2016/362], The Swedish Research Council [2012–1770, 2015–02483], ALF grants [138751, 146201 and 4307771, HTA–VGR 6011], the Mrs. Mary von Sydow Foundation, the Anna and Edvin Berger Foundation and the Assar Gabrielsson’s Foundation [FB 18-19].